AR046938A1 - Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares - Google Patents
Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similaresInfo
- Publication number
- AR046938A1 AR046938A1 ARP040104493A ARP040104493A AR046938A1 AR 046938 A1 AR046938 A1 AR 046938A1 AR P040104493 A ARP040104493 A AR P040104493A AR P040104493 A ARP040104493 A AR P040104493A AR 046938 A1 AR046938 A1 AR 046938A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- compound
- formula
- independently
- halo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
- C07C251/60—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
- C07C255/26—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups, amino groups and singly-bound oxygen atoms bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
- C07C259/14—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Abstract
Se describen procedimientos para preparar 10-amino-3-hidroxi-4-oxo-4,6,7,8,9,10-hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuestos relacionados. Se describe también la preparacion de derivados de carboxamida a partir de estos carboxilatos. Las carboxamidas son inhibidoras de integrasa del VIH y son utiles para tratar la infeccion con VIH y el SIDA. Reivindicacion 1: Un procedimiento para preparar un compuesto de formulas (1) o (2), el cual comprende: poner en contacto un compuesto de formula (3), o un compuesto de formula (4), con una base fuerte para obtener compuesto de formula (1); o poner en contacto un compuesto de formula (5), un compuesto de formula (6), un compuesto de formula (7), o un compuesto de formula (8), con una base fuerte para obtener el compuesto de formula (2); en el que W es un grupo protector amina; L es un grupo activador hidroxi; Y es halo; R1 es: a) H; b) alquilo (C1-6); c) alquilo (C1-6) sustituido con O-alquilo(C1-6), cicloalquilo (C3-8), o arilo, en el que el cicloalquilo está opcionalmente sustituido con de 1 a 3 grupos alquilo (C1-6) y el arilo está opcionalmente sustituido con de 1 a 5 sustituyentes cada uno de los cuales es independientemente alquilo (C1-6), O-alquilo (C1-6), CF3, OCF3, halo, CN o NO2; o d) arilo el cual está opcionalmente sustituido con de 1 a 5 sustituyentes cada uno de los cuales es independientemente alquilo (C1-6), O-alquilo(C1-6), CF3, OCF3, halo, CN, o NO2; R2, R4, cada R4, cada R5, R6, y R7 son independientemente: a) H; b) alquilo (C1-6); o c) alquilo (C1-6) sustituido con O-alquilo(C1-6), cicloalquilo (C3-8), o arilo, en el que el cicloalquilo está opcionalmente sustituido con de 1 a 3 grupos alquilo (C1-6) y el arilo está opcionalmente sustituido con de 1 a 5 sustituyentes cada uno de los cuales es independientemente alquilo (C1-6), O-alquilo (C1-6), CF3, OCF3, halo, CN o NO2; R8 es i) una mezcla de RA y RB, en la que RA y Rb son diferentes grupos alquilo (C1-6), o es ii) RC, en el que RC es un alquilo (C1-6); cada arilo es independientemente fenilo o naftilo; y n es un numero entero igual a cero, 1, 2 o 3; T es un grupo de formulas (9), U1, U2 y U3 se seleccionan cada uno independientemente del grupo que consiste en H, halo, alquilo (C1-6), O-alquilo(C1-6), fluoroalquilo (C1-6), -SO2-alquilo(C1-6), C(=O)-NH-(alquilo (C1-6)), C(=O)-N-(alquilo (C1-6))2, y HetA; V1 es H, halo, alquilo (C1-6), o fluoroalquilo (C1-6); y cada HetA es independientemente un anillo heteroaromático de 5 o 6 miembros de 1 a 4 heteroátomos seleccionados independientemente de N, O y S, en el que el anillo heteroaromático se sustituye opcionalmente con 1 o 2 grupos alquilo (C1-6).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52870403P | 2003-12-12 | 2003-12-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR046938A1 true AR046938A1 (es) | 2006-01-04 |
Family
ID=34710093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040104493A AR046938A1 (es) | 2003-12-12 | 2004-12-02 | Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares |
Country Status (8)
Country | Link |
---|---|
US (1) | US20070142635A1 (es) |
EP (1) | EP1694678A2 (es) |
JP (1) | JP2007513958A (es) |
AR (1) | AR046938A1 (es) |
AU (1) | AU2004303856A1 (es) |
CA (1) | CA2547159A1 (es) |
TW (1) | TW200530198A (es) |
WO (1) | WO2005061501A2 (es) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003292437A1 (en) * | 2002-12-27 | 2004-07-22 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Tetrahydro-4h-pyrido(1,2-a)pyrimidines and related compounds useful as hiv integrase inhibitors |
WO2004062613A2 (en) | 2003-01-13 | 2004-07-29 | Bristol-Myers Squibb Company | Hiv integrase inhibitors |
US7273859B2 (en) | 2004-05-12 | 2007-09-25 | Bristol-Myers Squibb Company | HIV integrase inhibitors: cyclic pyrimidinone compounds |
US7115601B2 (en) | 2004-05-18 | 2006-10-03 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
US7173022B2 (en) | 2004-05-28 | 2007-02-06 | Bristol-Myers Squibb Company | Bicyclic heterocycles as HIV integrase inhibitors |
US7176196B2 (en) | 2004-05-28 | 2007-02-13 | Bristol-Myers Squibb Company | Bicyclic heterocycles as HIV integrase inhibitors |
US7157447B2 (en) | 2004-05-28 | 2007-01-02 | Bristol-Myers Squibb Company | Bicyclic heterocycles as HIV integrase inhibitors |
US7192948B2 (en) | 2004-05-28 | 2007-03-20 | Bristol-Myers Squibb Company | Bicyclic heterocycles as HIV integrase inhibitors |
WO2006060225A2 (en) * | 2004-11-23 | 2006-06-08 | Merck & Co., Inc. | Process for asymmetric synthesis of hexahydropyrimido[1,2-a] azepine-2-carboxamides and related compounds |
US7494984B2 (en) | 2005-08-31 | 2009-02-24 | Bristol-Myers Squibb Company | Substituted imidazo[1,2-a]pyrimidines as HIV viral DNA integrase inhibitors |
WO2007059125A2 (en) | 2005-11-15 | 2007-05-24 | Bristol-Myers Squibb Company | Hiv integrase inhibitors |
US7902182B2 (en) | 2005-11-16 | 2011-03-08 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
US8039458B2 (en) | 2005-11-17 | 2011-10-18 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
WO2007143446A1 (en) | 2006-05-30 | 2007-12-13 | Bristol-Myers Squibb Company | Spiro-condensed heterotricyclic compounds as hiv integrase inhibitors |
US7893055B2 (en) | 2006-06-28 | 2011-02-22 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
US7763630B2 (en) | 2007-06-06 | 2010-07-27 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
US8129398B2 (en) | 2008-03-19 | 2012-03-06 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
CN102239172A (zh) * | 2008-10-06 | 2011-11-09 | 默沙东公司 | Hiv整合酶抑制剂 |
US8143244B2 (en) | 2009-02-26 | 2012-03-27 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
US8383639B2 (en) | 2009-10-15 | 2013-02-26 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
US8835411B2 (en) | 2010-12-10 | 2014-09-16 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
US8846659B2 (en) | 2010-12-10 | 2014-09-30 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
WO2014008636A1 (en) * | 2012-07-11 | 2014-01-16 | Merck Sharp & Dohme Corp. | Macrocyclic compounds as hiv integrase inhibitors |
WO2014099586A1 (en) | 2012-12-17 | 2014-06-26 | Merck Sharp & Dohme Corp. | 4-pyridinonetriazine derivatives as hiv integrase inhibitors |
US9493479B2 (en) | 2013-04-16 | 2016-11-15 | Merck Sharp & Dohme Corp. | Substituted pyrido[1,2-a]pyrazines as HIV integrase inhibitors |
SI2997033T1 (en) | 2013-05-17 | 2018-04-30 | Merck Sharp & Dohme Corp. | FUZYCLE TRICYCLE HETEROCYCLIC COMPOUNDS AS HIV INTEGRATED INHIBITORS |
US9951079B2 (en) | 2013-06-13 | 2018-04-24 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as HIV integrase inhibitors |
JP6081662B2 (ja) | 2013-09-27 | 2017-02-15 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | Hivインテグラーゼ阻害薬として有用な置換されたキノリジン誘導体 |
CN107108540B (zh) * | 2014-11-04 | 2019-08-02 | 日产化学工业株式会社 | 丁内酯化合物和制造方法 |
WO2016187788A1 (en) | 2015-05-25 | 2016-12-01 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds useful for treating hiv infection |
EP3377066B1 (en) | 2015-11-17 | 2021-04-07 | Merck Sharp & Dohme Corp. | Amido-substituted pyridotriazine derivatives useful as hiv integrase inhibitors |
US10544155B2 (en) | 2015-12-15 | 2020-01-28 | Merck Sharp & Dohme Corp. | Spirocyclic quinolizine derivatives useful as HIV integrase inhibitors |
WO2017113288A1 (en) | 2015-12-31 | 2017-07-06 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as hiv integrase inhibitors |
CN110062627A (zh) | 2016-12-02 | 2019-07-26 | 默沙东公司 | 可用作hiv整合酶抑制剂的三环杂环化合物 |
JOP20190130A1 (ar) | 2016-12-02 | 2019-06-02 | Merck Sharp & Dohme | مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv) |
US10786488B2 (en) | 2017-01-26 | 2020-09-29 | Merck Sharp & Dohme Corp. | Substituted quinolizine derivatives useful as HIV integrase inhibitors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU185925B (en) * | 1977-12-29 | 1985-04-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing compounds with nitrogen bridge head |
HU184058B (en) * | 1977-12-29 | 1984-06-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing new compounds with nitrogen bridge head |
GB0017676D0 (en) * | 2000-07-19 | 2000-09-06 | Angeletti P Ist Richerche Bio | Inhibitors of viral polymerase |
DK1441735T3 (da) * | 2001-10-26 | 2006-06-12 | Angeletti P Ist Richerche Bio | N-substituerede hydroxypyrimidinon-carboxamid-inhibitorer af HIV-integrase |
DE60218511T2 (de) * | 2001-10-26 | 2007-10-25 | Istituto Di Richerche Di Biologia Molecolare P. Angeletti S.P.A. | Dihydroxypyrimidin-carbonsäueramid-hemmer der hiv-integrase |
GB0201179D0 (en) * | 2002-01-18 | 2002-03-06 | Angeletti P Ist Richerche Bio | Therapeutic agents |
AU2003292437A1 (en) * | 2002-12-27 | 2004-07-22 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Tetrahydro-4h-pyrido(1,2-a)pyrimidines and related compounds useful as hiv integrase inhibitors |
-
2004
- 2004-12-02 AR ARP040104493A patent/AR046938A1/es unknown
- 2004-12-03 TW TW093137279A patent/TW200530198A/zh unknown
- 2004-12-08 WO PCT/US2004/041115 patent/WO2005061501A2/en not_active Application Discontinuation
- 2004-12-08 EP EP04813437A patent/EP1694678A2/en not_active Withdrawn
- 2004-12-08 JP JP2006543954A patent/JP2007513958A/ja active Pending
- 2004-12-08 US US10/582,414 patent/US20070142635A1/en not_active Abandoned
- 2004-12-08 AU AU2004303856A patent/AU2004303856A1/en not_active Abandoned
- 2004-12-08 CA CA002547159A patent/CA2547159A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2007513958A (ja) | 2007-05-31 |
CA2547159A1 (en) | 2005-07-07 |
AU2004303856A1 (en) | 2005-07-07 |
TW200530198A (en) | 2005-09-16 |
WO2005061501A2 (en) | 2005-07-07 |
WO2005061501A3 (en) | 2006-04-06 |
US20070142635A1 (en) | 2007-06-21 |
EP1694678A2 (en) | 2006-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR046938A1 (es) | Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares | |
RU2309951C2 (ru) | Производные никотинамида, способы их получения, фармацевтическая композиция на их основе и применение | |
ECSP034475A (es) | Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1 | |
AR050267A1 (es) | Derivados de urea ciclicos sustituidos con heterociclo, su preparacion y su uso farmaceutico como inhibidores de quinasa | |
AR060316A1 (es) | Azaindoles de utilidad como inhibidores de janus quinasas | |
AR052903A1 (es) | Compuestos de bis arilo y heteroarilo sustituidos como antagonistas selectivos de 5ht2a, composiciones farmaceuticas que los contienen y su empleo en el tratamiento de trastornos del sueno. | |
AR016762A1 (es) | Compuestos del acido 4-bromo o 4-yodo fenilamino benzohidroxamico, formulaciones farmaceuticas y uso del mismo | |
RS51471B (en) | BIPHYNYLOXYXIC ACID DERIVATIVES FOR TREATMENT OF RESPIRATORY DISEASES | |
AR062680A1 (es) | Sintesis de 2-(piridin-2-ilamino) pirido [2,3-d] pirimidin-7-onas | |
AR035815A1 (es) | Derivados de piperidina, un proceso para su preparacion, composiciones y combinaciones farmacéuticas que comprenden a dichos derivados | |
AR058287A1 (es) | Derivados de isoquinolina y composicion farmaceutica | |
RS51888B (en) | N- (PHENYL (PIPERIDIN-2-IL) METHYL) BENZAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY | |
AR006720A1 (es) | Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende | |
NZ517696A (en) | Biaryl ether derivatives useful as monoamine reuptake inhibitors | |
AR046793A1 (es) | Derivados de pirazol, antagonistas del receptor de la orexina | |
UY29312A1 (es) | Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones | |
PE20200665A1 (es) | Compuestos espirociclicos y sus metodos de preparacion y uso | |
YU40998A (sh) | Derivati supstituisanog 1,2,3,4-tetrahidronaftalina | |
SE0101579D0 (sv) | New compounds | |
AR074128A1 (es) | Derivados de 4-[2-(2-fluorofenoximetil)fenil] piperidina, composiciones farmaceuticas que los contienen, metodo de preparacion, compuestos intermediarios de dicho proceso y uso de los mismos para el tratamiento de dolores neuropaticos, mal de alzheimer y otras enfermedades relacionadas con el snc. | |
AR042362A1 (es) | Derivados de 3h-quinazolin-4-ona, proceso de obtencion y composiciones farmaceuticas que los contienen | |
HUP0201722A2 (hu) | Gyógyászati készítmények alkoholizmus és alkoholfüggőség kezelésére | |
AR071514A1 (es) | Derivados de aminopiridina | |
AR110432A1 (es) | Amidas aromáticas de ácidos carboxílicos | |
YU47219B (sh) | Antivirusna tetrahidroimidazo (1,4) benzodiazepin-2-tiona jedinjenja i postupak za njihovo dobijanje |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |